A/Prof Ngaire Elwood
A/Prof Ngaire Elwood
Details
Role
Team Leader / Dir. Cord Blood Bank
Research area
Stem Cell Medicine
Group
Blood Development
Contact
Available for student supervision
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..
Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.
Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.
Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord...
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..
Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.
Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.
Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Top Publications
- Fahey, MC, Paton, MCB, Haddad, L, Foreman, K, Martin, M, Novak, I, Barnett, M, Krause-Onwukwe, M, Webb, A, Elwood, N, et al. Safety and Feasibility of Autologous Cord Blood Infusion for Cerebral Palsy: A Case Report With Ethical and Translational Considerations.. J Paediatr Child Health 62(3) : 471 -474 2026 view publication
- Paton, MCB, Benders, M, Blatch-Williams, R, Dallimore, E, Edwards, A, Elwood, N, Facer, K, Finch-Edmondson, M, Garrity, N, Gordon, A, et al. Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024).. Pediatr Res 98(3) : 777 -785 2025 view publication
- Razak, A, Connelly, K, Hunt, RW, Miller, SL, McDonald, CA, Jenkin, G, Zhou, L, Paton, MC, Martin, M, Liu, L, et al. Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol.. BMJ Open 15(6) : e100389 2025 view publication
- Elwood, N, Whish-Wilson, J, Abberton, K, Choi, K, Tsoutras, D, Tian, P. CREATION IN-HOUSE OF A GMP-COMPLIANT INDUCED PLURIPOTENT STEM CELL (IPSC) MASTER CELL BANK (MCB) FROM BANKED CORD BLOOD (CB). Cytotherapy 26(6) : s224 2024 view publication
- Brizard, CP, Elwood, NJ, Kowalski, R, Horton, SB, Jones, BO, Hutchinson, D, Zannino, D, Sheridan, BJ, Butt, W, Cheung, MMH, et al. Safety and feasibility of adjunct autologous cord blood stem cell therapy during the Norwood heart operation.. J Thorac Cardiovasc Surg 166(6) : 1746 -1755 2023 view publication
Page 1 of 15
Career information
Share //
